According to an article in the Malaysian Mail on September 7th, the High Court of Malaysia has rejected an application from an anti-tobacco organization to halt the exemption of liquid nicotine from the list of hazardous substances, while awaiting judicial review.
These three citizen groups had hoped for the court to enact a law that temporarily reinstates liquid nicotine as a toxic substance on the list, pending the resolution of the Health Minister's lawsuit. However, their attempts were unsuccessful.
High Court judge Ahmad Farid Wan Salleh has rejected the application from three civil society organizations to "suspend" or temporarily halt the decision of Health Minister Zaliha Mustafa to remove e-cigarette liquid from the list of poisonous substances.
In rejecting the application for suspension, the judge stated that the three civic organizations would need to demonstrate the presence of exceptional circumstances in order to establish the reasonableness of suspending the Health Minister's directive issued on March 31st.
Lawyer Shanmuga of the civil society group expressed that the application for suspension has been rejected. He stated that the high court mentioned that his client did not provide sufficient detailed reasons for the suspension. However, he mentioned that the high court did agree to expedite the hearing of this lawsuit and has scheduled it for December 6th.
Before e-cigarette liquids and e-cigarette gels were removed from the list of poisons, non-medical therapeutic products - which were previously categorized as toxic - were prohibited from being illegally sold to children. Now, these products can be openly and legally sold to children.
If these three civic organizations succeed in obtaining temporary suspension, these e-cigarette liquid products will temporarily be brought back under the jurisdiction of the Ministry of Health, preventing their legal sale to children.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
